植田 晃広

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Nerve Growth Factor 96%
3. PC12 Cells 81%
4. Glycolipids 73%
5. G(M1) Ganglioside 72%
6. Clioquinol 68%
7. Cerebrospinal Fluid 59%
8. Antibodies 59%
9. Galactosidases 58%
10. Nerve Growth Factor Receptors 55%
11. Parkinsonian Disorders 53%
12. Encephalitis 51%
13. Primary Dysautonomias 50%
14. Meningitis 46%
15. Lipids 44%
16. Alzheimer Disease 44%
17. Progressive Encephalomyelitis with Rigidity 40%
18. Neuromyelitis Optica 39%
19. Serum 38%
20. juzentaihoto 37%
21. neurotropin 36%
22. fibrin fragment D 36%
23. Biomarkers 36%
24. Glycosphingolipids 35%
25. Brain 35%
26. Neutral Glycosphingolipids 34%
27. Neuronal Outgrowth 34%
28. Nerve Growth Factors 33%
29. Aquaporin 4 33%
30. Nemaline Myopathies 33%
31. Brachial Plexus Neuritis 32%
32. Autoantibodies 32%
33. 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane 32%
34. Multiple System Atrophy 32%
35. Peripheral Nerves 32%
36. Orthomyxoviridae 31%
37. Stroke 30%
38. Atrial Fibrillation 29%
39. Passive Immunization 29%
40. Thiamine Deficiency 29%
41. Viral Encephalitis 29%
42. alpha-Galactosidase 29%
43. Ceramides 29%
44. Chronic Inflammatory Demyelinating Polyradiculoneuropathy 28%
45. Sphingomyelins 28%
46. Sphingolipids 28%
47. Magnetic Resonance Imaging 28%
48. Dementia 28%
49. Glycine Receptors 28%
50. Sphingomyelin Phosphodiesterase 27%